Healthy Participant

130 drugs in development·30 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(31)
Phase 1(73)
DrugCompany
[13C2,15N3]-tebapivatAGIOS PHARMACEUTICALS, INC. (AGIO)
[14C]-tebapivatAGIOS PHARMACEUTICALS, INC. (AGIO)
[14c]azd5004ASTRAZENECA PLC (AZN)
[14c]azd5004 solution for infusionASTRAZENECA PLC (AZN)
100 µci [14c] hmpl-306HUTCHMED (China) Limited (HCM)
aci-19764 at dose a1AC Immune SA (ACIU)
aci-19764 at dose a2AC Immune SA (ACIU)
aci-19764 at dose a3AC Immune SA (ACIU)
aci-19764 at dose a4AC Immune SA (ACIU)
aci-19764 at dose a5AC Immune SA (ACIU)
aci-19764 at dose a6AC Immune SA (ACIU)
aci-19764 at dose b1AC Immune SA (ACIU)
aci-19764 at dose b2AC Immune SA (ACIU)
aci-19764 at dose b3AC Immune SA (ACIU)
AG-236AGIOS PHARMACEUTICALS, INC. (AGIO)
Andexanet alfaASTRAZENECA PLC (AZN)
ApixabanASTRAZENECA PLC (AZN)
aro-033ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
axatilimabIncyte Corp. (INCY)
azd5004 film-coatedASTRAZENECA PLC (AZN)
BW-50218 InjectionCidara Therapeutics, Inc. (CDTX)
CasdatifanArcus Biosciences, Inc. (RCUS)
CDX-622Celldex Therapeutics, Inc. (CLDX)
combined oral contraceptiveDeciphera Pharmaceuticals, Inc. (DCPH)
CRB-913Crinetics Pharmaceuticals, Inc. (CRNX)
CRB-913Corbus Pharmaceuticals Holdings, Inc. (CRBP)
dextromethorphanASTRAZENECA PLC (AZN)
elecoglipronASTRAZENECA PLC (AZN)
esomeprazoleIncyte Corp. (INCY)
ethinyl estradiol/levonorgestrelASTRAZENECA PLC (AZN)
evolocumab drug substance aAMGEN INC (AMGN)
evolocumab drug substance bAMGEN INC (AMGN)
ezetimibe stpASTRAZENECA PLC (AZN)
famotidineIncyte Corp. (INCY)
hmpl-760HUTCHMED (China) Limited (HCM)
hmpl-760HUTCHMED (China) Limited (HCM)
inca033989Incyte Corp. (INCY)
incb000631Incyte Corp. (INCY)
incb099280Incyte Corp. (INCY)
incb123667Incyte Corp. (INCY)
incb160058Incyte Corp. (INCY)
incb161734Incyte Corp. (INCY)
itraconazoleIncyte Corp. (INCY)
ItraconazoleArcus Biosciences, Inc. (RCUS)
KT-579Kymera Therapeutics, Inc. (KYMR)
levonorgestrel/ethinyl estradiolBlueprint Medicines Corp (BPMC)
ly3009104ELI LILLY & Co (LLY)
LY4060874ELI LILLY & Co (LLY)
midazolamBlueprint Medicines Corp (BPMC)
MitiglinideASTRAZENECA PLC (AZN)
moxifloxacinELI LILLY & Co (LLY)
mRNA-0184Moderna, Inc. (MRNA)
nal erTrevi Therapeutics, Inc. (TRVI)
nintedanibTrevi Therapeutics, Inc. (TRVI)
nnc0113-6856Novo Nordisk A/S (NVO)
nnc0650-0013 aNovo Nordisk A/S (NVO)
pf-08642534PFIZER INC (PFE)
PhenytoinArcus Biosciences, Inc. (RCUS)
PioglitazoneASTRAZENECA PLC (AZN)
pmn310ProMIS Neurosciences Inc. (PMN)
povorcitinibIncyte Corp. (INCY)
QuemliclustatArcus Biosciences, Inc. (RCUS)
rabeprazoleHUTCHMED (China) Limited (HCM)
rabeprazoleHUTCHMED (China) Ltd (HMDCF)
rabeprazoleELI LILLY & Co (LLY)
rifampinIncyte Corp. (INCY)
RivaroxabanASTRAZENECA PLC (AZN)
rosuvastatinDeciphera Pharmaceuticals, Inc. (DCPH)
semaglutide cNovo Nordisk A/S (NVO)
semaglutide jNovo Nordisk A/S (NVO)
syh2085NYMOX PHARMACEUTICAL CORP (NYMXF)
tbp-pi-hbrSpero Therapeutics, Inc. (SPRO)
ziltivekimab dNovo Nordisk A/S (NVO)
Phase 1/Phase 2(1)

Compare drugs

Frequently asked questions

How many drugs are in development for Healthy Participant?

BioSniper tracks 130 drugs in development for Healthy Participant across 30 companies.

How many clinical trials target Healthy Participant?

There are 2 clinical trials targeting Healthy Participant tracked by BioSniper.

Deep-dive into Healthy Participant

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Healthy Participant — Drugs in Development & Clinical Trials | BioSniper